Prognostic significance of change in mammographic density among ER+ breast cancer patients treated with tamoxifen

Sarah Nyante, PhD, Postdoctoral Fellow, Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute

When Jan 24, 2014 from 01:00 PM to 02:00 PM (US/Eastern / UTC-500)
Where 2101G McGavran-Greenberg Hall
Add event to calendar iCal

Cancer Epidemiology Seminar